Morepen Laboratories Limited — Board Meeting, 14-11-2025: Outcome of Board Meeting
14-11-2025 | 03:16 pm
14-11-2025 | 03:16 pm
Morepen Labs' board approved financial results for the quarter and half-year. Consolidated Net Profit for H1 FY26 was Rs 51.62 Cr. The company booked a Rs 25.83 Cr exceptional gain from Dr. Morepen Ltd ceasing to be a subsidiary.
No comments yet. Be the first to comment!
